Curative Biosciences Stock Analysis
| CBDX Stock | USD 0.0001 0.00 0.00% |
Curative Biosciences is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Curative Biosciences pink sheet analysis is to determine its intrinsic value, which is an estimate of what Curative Biosciences is worth, separate from its market price. There are two main types of Curative Biosciences' stock analysis: fundamental analysis and technical analysis.
The Curative Biosciences pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Curative |
Curative Pink Sheet Analysis Notes
About 76.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.03. Curative Biosciences had not issued any dividends in recent years. The entity had 1:100 split on the 28th of October 2013. Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida. Curative Biosciences is traded on OTC Exchange in the United States.The quote for Curative Biosciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Curative Biosciences please contact Richard Damion at 949-287-3164 or go to https://curativebio.com.Curative Biosciences Investment Alerts
| Curative Biosciences generated a negative expected return over the last 90 days | |
| Curative Biosciences has some characteristics of a very speculative penny stock | |
| Curative Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (53.2 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Curative Biosciences currently holds about 982 in cash with (12.8 K) of positive cash flow from operations. | |
| Roughly 76.0% of the company shares are held by company insiders |
Curative Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Curative Biosciences's market, we take the total number of its shares issued and multiply it by Curative Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Curative Biosciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Curative Biosciences Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Curative Biosciences middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Curative Biosciences. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Curative Biosciences Outstanding Bonds
Curative Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Curative Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Curative bonds can be classified according to their maturity, which is the date when Curative Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
About Curative Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Curative Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Curative shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Curative Biosciences. By using and applying Curative Pink Sheet analysis, traders can create a robust methodology for identifying Curative entry and exit points for their positions.
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida. Curative Biosciences is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Curative Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Additional Tools for Curative Pink Sheet Analysis
When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.